J 2022

Diagnosis and classification of optic neuritis

PETZOLD, Axel, Clare L FRASER, Mathias ABEGG, Raed ALROUGHANI, Daniah ALSHOWAEIR et. al.

Basic information

Original name

Diagnosis and classification of optic neuritis

Authors

PETZOLD, Axel (guarantor), Clare L FRASER, Mathias ABEGG, Raed ALROUGHANI, Daniah ALSHOWAEIR, Regina ALVARENGA, Cecile ANDRIS, Nasrin ASGARI, Yael BARNETT, Roberto BATTISTELLA, Raed BEHBEHANI, Thomas BERGER, Mukharram M BIKBOV, Damien BIOTTI, Valerie BIOUSSE, Antonella BOSCHI, Milan BRÁZDIL (203 Czech Republic, belonging to the institution), Andrei BREZHNEV, Peter A CALABRESI, Monique CORDONNIER, Fiona COSTELLO, Franz M CRUZ, Leonardo Provetti CUNHA, Smail DAOUDI, Romain DESCHAMPS, de Seze JEROME, Ricarda DIEM, Masoud ETEMADIFAR, Jose FLORES-RIVERA, Pedro FONSECA, Jette FREDERIKSEN, Elliot FROHMAN, Teresa FROHMAN, Caroline Froment TILIKETE, Kazuo FUJIHARA, Alberto GALVEZ, Riadh GOUIDER, Fernando GRACIA, Nikolaos GRIGORIADIS, Jose M GUAJARDO, Mario HABEK, Marko HAWLINA, Elena H MARTINEZ-LAPISCINA, Juzar HOOKER, Jyh Yung HOR, William HOWLETT, Yumin HUANG-LINK, Zhannat IDRISSOVA, Zsolt ILLES, Jasna JANCIC, Panitha JINDAHRA, Dimitrios KARUSSIS, Emilia KERTY, Ho Jin KIM, Wolf LAGREZE, Letizia LEOCANI, Netta LEVIN, Petra LISKOVA, Yaou LIU, Youssoufa MAIGA, Romain MARIGNIER, Chris MCGUIGAN, Dalia MEIRA, Harold MERLE, Mario L R MONTEIRO, Anand MOODLEY, Frederico MOURA, Silvia MUNOZ, Sharik MUSTAFA, Ichiro NAKASHIMA, Susana NOVAL, Carlos OEHNINGER, Olufunmilola OGUN, Afekhide OMOTI, Lekha PANDIT, Friedemann PAUL, Gema REBOLLEDA, Stephen REDDEL, Konrad REJDAK, Robert REJDAK, Alfonso J RODRIGUEZ-MORALES, Marie-Benedicte ROUGIER, Maria Jose SA, Bernardo SANCHEZ-DALMAU, Deanna SAYLOR, Ismail SHATRIAH, Aksel SIVA, Hadas STIEBEL-KALISH, Gabriella SZATMARY, Linh TA, Silvia TENEMBAUM, Huy TRAN, Yevgen TRUFANOV, van Pesch VINCENT, An-Guor WANG, Mike P WATTJES, Ernest WILLOUGHBY, Magd ZAKARIA, Jasmin ZVORNICANIN, Laura BALCER and Gordon T PLANT

Edition

Lancet Neurology, London, UK, Elsevier, 2022, 1474-4422

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 48.000

RIV identification code

RIV/00216224:14110/22:00128089

Organization unit

Faculty of Medicine

UT WoS

000898849800022

Keywords in English

optic neuritis; diagnosis; classification

Tags

Tags

International impact, Reviewed
Změněno: 18/1/2023 12:32, Mgr. Tereza Miškechová

Abstract

V originále

There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not available. This reality means that the diagnosis of disorders that have optic neuritis as the first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease. Epidemiological data show that, cumulatively, optic neuritis is most frequently caused by many conditions other than multiple sclerosis. Worldwide, the cause and management of optic neuritis varies with geographical location, treatment availability, and ethnic background. We have developed diagnostic criteria for optic neuritis and a classification of optic neuritis subgroups. Our diagnostic criteria are based on clinical features that permit a diagnosis of possible optic neuritis; further paraclinical tests, utilising brain, orbital, and retinal imaging, together with antibody and other protein biomarker data, can lead to a diagnosis of definite optic neuritis. Paraclinical tests can also be applied retrospectively on stored samples and historical brain or retinal scans, which will be useful for future validation studies. Our criteria have the potential to reduce the risk of misdiagnosis, provide information on optic neuritis disease course that can guide future treatment trial design, and enable physicians to judge the likelihood of a need for long-term pharmacological management, which might differ according to optic neuritis subgroups.